SCHEMBL25021702

SCHEMBL25021702

C=CC[C@@H](CCCC)COc1nc2c(c(N(CCC)CC(C)CC#N)n1)CCNC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21896256 0.86 — —
SCHEMBL21912184 0.85 — —
SCHEMBL25020009 0.79 — —
SCHEMBL21912768 0.78 — —
SCHEMBL19637187 0.78 — —
SCHEMBL22087711 0.78 KRAS (0.34) —
SCHEMBL21912169 0.77 — —
SCHEMBL21846279 0.76 KRAS (0.36) —
SCHEMBL22725374 0.75 KDM4E (0.30) —
SCHEMBL21896283 0.74 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3710439-B1 KRAS G12C INHIBITORS MIRATI THERAPEUTICS INC (US) 2023-02-15 — — EP disclosed
Send feedback